24/12/2025
Bevacizumab (Avastin) has at last been approved for use on advanced bowel cancer in NHS England - What a great Christmas present for thousands of people.
I was one of two Expert Patients at the hearing and I have to say that the review panel was respectful and seemed to truly value the patient perspective. I’ve wanted to share this news but had to sign a confidentiality agreement.
I’ve been campaigning for this for years as I was lucky enough to be on avastin and I’m sure it’s one of the reasons I’m still here.
I do want to say thank you to National Institute for Health and Care Excellence for introducing this new approach to reviewing medicines that have come off patent.
There is no doubt that this decision will be a game changer for so many people with stage 4 colorectal cancer.
HomeNewsNews articlesThousands more people with advanced bowel cancer to benefit as NICE approves bevacizumab biosimilarsMore than 7,000 people in England will now be able to access to a life-extending treatment for advanced bowel cancer.News24 December 2025NICE has today published final draft guida...